References

1. Seligmann M. Human lymphocyte subsets in health and disease. In: Yamamura T, Tada T, eds., Progress in Immunology. Tokyo: Academic Press, 1984;1047-1051.

2. Calligaris-Cappio F, Gobbi M, Bofill M, Janossy G. Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia. J Exp Med 1982;155:623-628.

3. Youinou P, MacKenzie L, Lamour A, Mageed RA, Lydyard PM. Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases. Eur J Clin Invest 1993;23:139-150.

4. Buskila D, Mackenzie LE, Shoenfeld Y, Youinou P, Lydyard PM. The biology of CD5+ B cells. In: Shoenfeld Y, Isenberg DA, eds., Natural autoantibodies. Their physiological role and regulatory significance. Boca Raton: CRC Press, 1993;125-142.

5. Youinou P, Buskila D, Mackenzie LZ, Shoenfeld Y, Lydyard PM. CD5-positive B cells and disease. In: Shoenfeld Y, Isenberg DA, eds., Natural Autoantibodies. Their Physiological Role and Regulatory Significance. Boca Raton: CRC Press, 1993; 143— 165.

6. Lydyard PM, Youinou P, Cooke A. CD5-positive B cells in rheumatoid arthritis and chronic lymphocytic leukemia. Immunol Today 1987;8:37-39.

7. Deane M, Mackenzie LE, Stevenson FK, Youinou PY, Lydyard PM, Mageed RA. The genetic basis of human Vh4 gene family-associated cross-reactive idiotype expression in CD5+ and CD5- cord blood B-lymphocytes clones. Scand J Immunol 1993;38:348-358.

8. Youinou P, MacKenzie L, Lamour A, Jamin C, Lydyard PM. Human CD5+ B cells and autoimmunity. Israel J Med Sci 1993;29:874-876.

9. Plater-Zyberk C, Maini RN, Lam K, Kennedy TD, Janossy G. A rheumatoid arthritis B cell susbset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthrit Rheumatol 1985;28:971-976.

10. Youinou P, Mackenzie LE, Jouquan J, Le Goff P, Lydyard PM. CD5-positive B cells in patients with rheumatoid arthritis: phorbol ester-mediated enhancement of detection. Ann Rheum Dis 1987;46:17-22.

11. Sowden JA, Roberts-Thomson PJ, Zola H. Evaluation of CD5-positive B cells in blood and synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1987;7:255-259.

12. Becker H, Weber C, Storch S, Federlin K. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity. Clin Immunol Immunopathol 1990;56:219-225.

13. Kazbay K, Osterland CK. The frequency of Leul + B cells in autoantibody positive and negative autoimmune diseases and in neonatal cord blood. Clin Exp Rheumatol 1990;8:231-235.

14. Dauphinee M, Tovar Z, Talal N. B cells expressing CD5 are increased in Sjogren's syndrome. Arthrit Rheumatol 1988;31:642-647.

15. Youinou P, Mackenzie LE, Le Masson G, Papadopou-los NM, Jouquan J, Pennec YL, Angelidis P, Katsikis P, Moutsopoulos HM, Lydyard PM. CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjogren's syndrome. J Autoimmun 1988;1:185-194.

16. Youinou P, Le Goff P, Renier JC, Hurez D, Miossec P, Morrow WJW. Relationship between rheumatoid arthritis and monoclonal gammopathy. J Rheumatol 1983;108:2105-215.

17. Rubin L, Urowitz MB, Pruzanski W. Systemic lupus erythematosus with paraproteinemia. Arthrit Rheumatol 1984;27:638-644.

18. Talal N, Bunim JJ. The development of malignant lymphoma in the course of Sjogren's syndrome. Am J Med 1964;36:529-540.

19. Talal N. Maintenance of autoimmunity. Autoimmun 1988; 1:703.

20. Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos NM, Moutsopoulos HM. Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with Sjogren's syndrome. Arthrit Rheumatol 1986;29:1098-1104.

21. Talal N, Asofsky R, Lightbody P. Immunoglobulin synthesis by salivary lymphoid cells in Sjogren's syndrome. J Clin Invest 1970;49:49-54.

22. Pablos JL, Carreira PE, Morillas L, Montalvo G, Ballestin C, Gomez-Reino JJ. Clonally expanded lymphocytes in the minor salivary glands of Sjogren's syndrome patients without lymphoproliferative disease. Arthrit Rheumatol 1994;37:1441-1444.

23. Youinou P, Pennec YL, Blaschek MA, Gentric A, Jouquan J, Lamour A, Angelidis P. Activation of peripheral blood lymphocytes in patients with primary Sjogren's syndrome. Rheumatol Int 1988;8:125-129.

24. Caligaris-Cappio F, Janossy G. Surface markers in chronic lymphoid leukemias of B cell type. Semin Hematol 1985;22:1-12.

25. Batata A, Shen B. Chronic lymphocytic leukemia with low lymphocyte count. Cancer 1993;71:2732-2738.

26. Gobbi M, Caligaris-Cappio F, Janossy G. Normal equivalent cells of B cell malignancies. Analysis with monoclonal antibodies. Br J Haematol 1983;54:393-403.

27. Den Ottolander GJ, Schuit HRE, Waayer JLM, Huibregtsen L, Hijmans W, Jansen J. Chronic B-cell leukemias. Relation between morphological and immunological features. Clin Immunol Immunopathol 1985;35:92-102.

28. Martin T, Pasquali JL. CD5-negative IgM rheumatoid factor B-cells in B-chronic lymphocytic leukemia and benign mixed cryoglobulinaemia. Leuk Lymphoma 1992;7:55-62.

29. Duhrsen U, Augener W, Zwingers T, Brittinger G. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders. Analysis of 637 cases, and comparison with myeloproliferative diseases. Br J Haematol 1987;67:235-239.

30. Hamblin TJ, Oscier DJ, Young BJ. Autoimmunity in chronic lymphocytic leukemia. J Clin Pathol 1986;39:713-716.

31. Gale RP, Foon KA. Biology of chronic lymphocytic leukemia. Semin Hematol 1987;24:204-229.

32. Grey HM, Rabellino F, Pirofsky B. Immunoglobulins on the surface of lymphocytes. IV. Distribution of hypogammaglobulinemia cellular immune dificiency and chronic lymphocytic leukemia. J Clin Invest 1971;50:2368-2377.

33. Kipps TJ, Fong S, Tomhave E, Chen PP, Goldfien RD, Carson DA. Immunoglobulin V gene utilisation. In: Gale RP, Rai KR, eds., Chronic Lymphocytic Leukemia. Recent Progress and Future Direction. New York: Alan R Riss, 1987;115-121.

34. Broker BM, Klajman A, Youinou P, Jouquan J, Wor-man C, Murphy J, Mackenzie L, Quartey-Papafio R, Blaschek MA, Collins P, Lai S, Lydyard PM. Chronic lymphocytic leukemia cells secrete multispecific autoantibodies. J Autoimmun

35. Sthoeger ZM, Walkai M, Tse DB, Vinciguerra VP, Allen SL, Budman DR, Lichtman SM, Schulman P, Weusekberg LR, Chiorazzi N. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 1989;169:255-268.

36. Borche L, Lim A, Binet JL, Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 1990;76:562-569.

37. Seligmann M, Brouet JC. Antibody activity of human myeloma globulins. Semin Hematol 1973; 10:163— 175.

38. Buskila D, Abu-Shakra M, Amital-Teplizki H, Coates ARM, Krupp M, Sukenik S, Shoenfeld Y. Serum monoclonal antibodies derived from patients with multiple myeloma react with mycobacterial phospho-inositides and nuclear antigens. Clin Exp Immunol 1989;76:378-383.

39. Dellagi K, Brouet JC, Perreau J, Paulin D. Human monoclonal IgM with autoantibody activity against intermediate filaments. Proc Natl Acad Sci USA 1982;79:446-450.

40. Gentric A, Lydyard PM, Youinou P. Multispecific autoantibody reactivity of human monoclonal immunoglobulins. Eur J Int Med 1990;1:279-284.

41. Dighiero G, Guilbert B, Fermand JP, Lymberi P, Danon F, Avrameas S. Thrity-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglob-ulin and native DNA. Immunologic studies and clinical correlations. Blood 1983;62:264-270.

42. Seligmann M, Danon F, Mihaesco C, Fudenberg HH. Immunoglobulin abnormalities in families of patient with Waldenstrom's macroglobulinemia. Am J Med 1967;43:66-83.

43. Lockard Conley C, Misiti J, Laster AJ. Genetic factor predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medecine (Baltimore) 1980;59:323-334.

44. Youinou P, Le Goff P, Saleun JP, Rivât L, Morin JF, Fauchier C, Le Menn G. Familial occurrence of monoclonal gammapathies. Biomedicine 1978;28:226-232.

45. Youinou P, Fauchier C, Prou O, Rivat-Peran L, Jouquan J, Moysan JF, Le Menn G. Nonorgan-specific autoantibodies and immunoglobulin allotypes in relatives of patients with monoclonal gammopathy. Hum Hered 1985;35:227-231.

46. Youinou P, Mackenzie L, Katsikis PD, Merdrignac G, Isenberg DA, Tuaillon N, Lamour A, Le Goff P, Jouquan J, Drogou A, Muller S, Genetet B, Mout-sopoulos HM, Lydyard PM. The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arthrit Rheumatol 1990;33:339-348.

47. Lydyard PM, Youinou P. Physiology of CD5- positive B cells in health and disease. Fund Clin Immunol 1994;2:9-16.

48. Schroeder HW, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994;15:288-294.

49. Mantovani L, Wilder RL, Casali P. Human rheumatoid B-la (CD5+ B) cells make somatically hypermu-tated high affinity IgM rheumatoid factors. J Immunol 1993;151:473-488.

50. Fischer M, Klein U, Kppers R. Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vk genes lacking somatic mutation. J Clin Invest 1997;100:1667-1676.

51. Wang Z, Morris DL, Rothstein TL. Constitutive and inducible levels of erg-1 and c-myc early growth response gene expression in self-renewing B-l lymphocytes. Cell Immunol 1995;162:309-314.

52. Caligari-Cappio F. B-chronic lymphocytic leukemia: a malignacy of anti-self B cells. Blood 1996;87:2615-2620.

53. Boumpas DT, Eleftheriades EG, Barez S, Tsokos GC. Oncogene expression and regulation in normal lymphocytes and lymphocytes from patients with autoimmune diseases. Anticancer Res 1988;8:977-984.

54. Boumpas DT, Eleftheriades EG, Molina R, Barez S, Atkinson J, Older SA, Balow JE, Stokds GC. C-myc proto-oncogene expression in peripheral blood mononuclear cells from patients with primary Sjogren's syndrome. Arthrit Rheumatol 1990;33:49-56.

55. Kahan A, Gerfaux J, Kahan A, Joret AM, Menkes CJ, Amor B. Increased proto-oncogene expression in peripheral blood T lymphocytes from patients with systemic sclerosis. Arthrit Rheumatol 1989;32:430— 436.

56. Bissonnette RP, Escheverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992;359:552-554.

57. Cleary ML, Sklar J. Nucleotide sequence of a t( 14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985;82:7439-7443.

58. Schena M, Larsson LG, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F. Growth-and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 1992;79:2981-2989.

59. Emlen W, Niebur J, Kadera R. Accelarated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-3692.

60. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, Graninger WB. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes of patients with systemic lupus erythematosus. Arthrit Rheumatol 1994;37:1423-1430.

61. Sugai S, Saito I, Masaki Y, Takeshita S, Shimizu S, Tachibana J, Miyasaka N. Rearrangement of the rheumatoid factor related germline gene Vg and bcl-2 expression in patients with Sjogren's syndrome. Clin Immunol Immunopathol 1994;72:181-186.

62. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW. Enforced bcl-2 ex pression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991;88:8661-8665.

63. Friedman SM, Posnett DN, Dumang JR, Cole BC, Crow MK. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthrit Rheumatol 1991;34:468-480.

64. Trauth BC, Klas C, Peters AM J, Matzku S, Moller P, Falk W, Debatin KM. Krammer PH. Monoclonal antibody- mediated tumor regression by apoptosis. Science 1989;245:301-305.

65. Mandik L, Nguyen KAT, Erikson J. Fas receptor expression on B-lineage cells. Eur J Immunol 1995;25:3148-3154.

66. Masuda K, Wang J, Watanabe T. Reduced susceptibility to Fas-mediated apoptosis in B-l cells. Eur J Immunol 1997;27:449^155.

67. Mapara MY, Bargou R, Zugk C, Döhner H, Ustaoglu F, Jonker RR, Krammer PH, Dörken B. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 1993;23:702-708.

68. Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, Elkon KB. The apoptosis Fas protein in human systemic lupus erythematosus. J Clin Invest 1994;93:1029-1034.

69. Nagata S, Suda T. Fas and Fas ligand, lpr and gld mutations. Immunol Today 1995;16:39^13.

70. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Identification of a soluble form of the Fas molecule that protects cells from Fasmediated apoptosis. Science 1994;263:1759-1762.

© 2000 Elsevier Science B.V. All rights reserved. Cancer and Autoimmunity Y. Shoenfeld and M. E. Gershwin, editors

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment